Silexion Therapeutics SLXN Growth Metrics (2024-2026)

NASDAQ SLXN
$0.27 -0.04 (-13.76%)
As of: Sep 30, 2026 · 3:47 PM EDT
Reported Financials

Silexion Therapeutics Quarterly Growth Metrics

Periods 9 quarters
Latest Jun 2026

Silexion Therapeutics growth metrics data for the quarter ended Jun 2026. These growth metrics cover 9 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Interest Coverage Ratio (QoQ)Interest Cover (QoQ) -113.16%
Return on Assets [ROA] Growth (1y)ROA Growth (1y) -17514.00-7052.0050,226.0042,816.008,253.00-6248.00
Return on Assets [ROA] (QoQ)ROA (QoQ) -5662.00-42597.005,379.0025,366.004,800.0014,681.00-2031.00-9197.00-9701.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) 58,637.00-28217.00-287043.00
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) 12,363.0012,875.00-2058.00-51397.00-246463.00
Return on Equity [ROE] Growth (1y)ROE Growth (1y) -70814.00-701421.00
Return on Equity [ROE] (QoQ)ROE (QoQ) 105,833.001,190.00-64351.00-744094.00
Return on Invested Capital [ROIC] (QoQ)ROIC (QoQ) 15,775.00-2903.00

Silexion Therapeutics Growth Metrics API

Pull Silexion Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SLXN&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY